Diamond sponsor Invitrogen Corporation (NASDAQ: IVGN) is a global company with revenues of $1.15 billion. We provide products and services to pharmaceutical and biotechnology companies, as well as academic and government research institutions. More than 4,300 employees work for Invitrogen and we conduct business in over 70 countries. We offer more than 25,000 unique products and services to support disease research, drug discovery and commercial bio-production. The company’s areas of focus include Bioproduction, genomics, proteomics, bioinformatics, cell culture, and cell biology, among others. Importantly, we continue to expand our capabilities by partnering with the brightest minds in the world on revolutionary diagnostic methods and therapeutic treatments. Invitrogen’s product family includes many of the most widely recommended names in the industry, including Molecular Probes, BioReliance, Gibco, Cascade and Dynal Biotech. Our products can be found in nearly every major laboratory in the world. Many of the greatest medical discoveries of the last two decades were made using Invitrogen products, including the discovery of the AIDS virus, advancements in cancer treatment, and the development of tools to assist in stem cell research. Invitrogen’s Quest is to better the human condition through innovations in science and technology. Through our Passionate People Making a Difference program, we serve as good corporate citizens in the communities in which we live and work.

Exhibitor As a leading, innovation-driven pharmaceutical corporation, we believe that the best way to find the next generation of drugs is to use the next generation technologies. And, we have expanded our drug discovery and scientific computational research centre in Singapore to do just that. Lilly Singapore Centre for Drug Discovery focuses on drug discovery based on adult stem cell and epigenetic research in the areas of cancer and metabolic disorders. The Centre also conducts biomarker discovery in these areas, and scientific computational research and development in support of therapeutic areas of interest to Lilly. Lilly Singapore Centre for Drug Discovery is an integral part of Lilly and as a result, has the strong backing of one of the world’s leading pharmaceutical companies.

Exhibitor Fujitsu Asia Pte Ltd was established in Singapore in 1997 to provide leadership in business development, technology innovation and customer support as the regional headquarter for the Fujitsu group of companies in ASEAN. Building on Fujitsu's three decades of experience in Singapore and the broader Asian region, and with a pool of highly skilled engineering talent, Fujitsu Asia is dedicated to providing comprehensive integrated IT, telecommunications and networking solutions that deliver tangible business value, enabling customers to meet the challenges of the new global economy. Fujitsu Asia is a wholly owned subsidiary of Tokyo-based Fujitsu Limited (TSE: 6702), a leader in customer-centric IT and communications solutions for the global marketplace.

Exhibitor STARLIMS is recognized as one of the world's leading and fastest growing Laboratory Information Management Systems (LIMS) suppliers. STARLIMS has been at the forefront of developing state-of-the-art LIMS since 1987 and is the only publicly listed pure-play LIMS vendor (NASDAQ:LIMS). Our web-based solutions encompass the flexibilities to meet the needs of clients in the vast majority of laboratory environments. These include organizations in the public health, petrochemical, forensics, food & beverage, environmental, chemical industries and life sciences sector (pharmaceutical manufacturing, R&D, clinical trails and genetic screening and research). We are the only LIMS that has SDMS and ELN built on the same platform. STARLIMS is certified to ISO 9001:2000 for the Design, Development and Implementation of LIMS.